C4 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Globe Newswire•11/08/2026•07:00 ET
0
Whiz Insights
Cemsidomide’s Ongoing Phase 2 MOMENTUM Trial and Phase 1b Trial in Combination With Elranatamab Remain on Track to Deliver Clinical Data Readouts in 2027
Phase 1 Data Presented at European Hematology Association (EHA) 2026 Congress Further Support Cemsidomide’s Potential Best-in-Class Profile in Multiple Myeloma
Get started
Create a free account to read the full story.